DJIA 17,828.24 0.49 0.00%
NASDAQ 4,791.63 4.31 0.09%
S&P 500 2,067.56 -5.27 -0.25%
market minute promo

Medivation, Inc. (NASDAQ: MDVN)

115.89 1.06 (0.92%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MDVN $115.89 0.92%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $115.50
Previous Close $114.83
Daily Range $114.50 - $116.87
52-Week Range $54.37 - $116.87
Market Cap $9.0B
P/E Ratio 80.87
Dividend (Yield) $0.00 (0.0%)
Volume 501,613
Average Daily Volume 1,115,676
Current FY EPS $2.56





Medivation, Inc. (MDVN) Description

A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies. Website:

News & Commentary

Should Johnson & Johnson Buy Medivation Inc.?

Johnson & Johnson's top-selling prostate cancer treatment is facing a stiff challenger in Medivation's Xtandi, but an acquisition may not be in the cards.

Two mini flash crashes rock stock market

MDVN January 2017 Options Begin Trading

Dendreon Shares Plummet After It Files for Bankruptcy - Analyst Blog

Update: Medivation Q3 Earnings

The Next Chapter in Dendron's Troubled History: Chapter 11 Bankruptcy

5 Prescription Drugs Selling Like Hot Cakes

Gilead Sciences, Biogen, Johnson & Johnson, Medivation, and Celgene have some of the fastest growing drugs in biotechnology.

Medivation Q3 Earnings, Revenues Lag Estimates - Analyst Blog

Medivation Q3 Earnings, Revenues Lag Estimates - Analyst Blog

Major Upgrades And Downgrades In Friday's Market Action

3 Drugs Stocks Pushing The Industry Higher

See More MDVN News...

MDVN's Top Competitors

MDVN $115.89 (0.92%)
Current stock: MDVN
TMO $129.29 (0.49%)
Current stock: TMO
$0.00 (0.00%)
Current stock:
ILMN $190.89 (-0.53%)
Current stock: ILMN